Cargando…
Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
In Japan, the choice of anti-diabetic medication is officially recommended according to the patient’s glycemic condition and disease phenotype, unlike most other regions where metformin is recommended as the first-line medication. There has been an increase in the number of available glucose-lowerin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394044/ https://www.ncbi.nlm.nih.gov/pubmed/30819188 http://dx.doi.org/10.1186/s12933-019-0834-0 |